# South Korea Hydrophobic Interaction Chromatography Market > South Korea Hydrophobic Interaction Chromatography Market Research Report: Size, Share, Trend Analysis By Product and Service (Resins, Columns, Services, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.51% - **2024:** $ 16.72 Million - **2025:** $ 18.64 Million - **2035:** $ 55.43 Million - **Key Players:** GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Bio-Rad Laboratories (US), Agilent Technologies (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) **Report ID:** MRFR/MED/54728-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-hydrophobic-interaction-chromatography-market-56494 --- ## Market Summary ## **South Korea Hydrophobic Interaction Chromatography Market Overview****:** As per MRFR analysis, the South Korea Hydrophobic Interaction Chromatography Market Size was estimated at 3.22 (USD Million) in 2023.The South Korea Hydrophobic Interaction Chromatography Market Industry is expected to grow from 4.5(USD Million) in 2024 to 10.2 (USD Million) by 2035. The South Korea Hydrophobic Interaction Chromatography Market CAGR (growth rate) is expected to be around 7.723% during the forecast period (2025 - 2035). ### **Key South Korea Hydrophobic Interaction Chromatography Market Trends Highlighted** Research and development activities within the biopharmaceutical industry are continuously rising, resulting in the rapid expansion of South Korea’s Hydrophobic Interaction Chromatography market. Institutions and companies are focusing on automated therapeutic protein purification and monoclonal antibody production, which require sophisticated chromatographic methods, advanced automation, and artificial intelligence capabilities. Government subsidies and policies promoting the biotechnology industry also have a positive impact on the market, as biotechnologies are crucial for South Korea’s economic growth. The development of new HIC materials and technologies that are more affordable and efficient, tailored to South Korean laboratories that lead in biomanufacturing innovation, is one potential area of opportunity for market participants. There is a focus on automating and integrating HIC and other chromatographic systems, leading to increased reproducibility and process optimization by South Korean researchers and QC labs. Industrial-academic collaboration is on the rise, which means that there are various educational schemes aimed at increasing the number of skilled professionals able to apply HIC methods in the region. The constant evolution of analytical tools and data management technologies creates new opportunities for better integration and analysis of data in bioprocessing systems. On the other hand, there is a growing focus on sustainable hydrophobic interaction chromatography, which is increasing investment in green materials and processes. To stay relevant in the moving market of South Korea, it will be important for manufacturers to adopt the new changes in trends and fulfill the requirements of the biotechnology industry. ## **South Korea Hydrophobic Interaction Chromatography Market Drivers** ### **Increase in Biopharmaceutical Production** The South Korea Hydrophobic Interaction Chromatography Market Industry is expected to experience significant growth due to the increasing production of biopharmaceuticals. South Korea is emerging as a major hub for biopharmaceutical manufacturing, with a focus on biologics and biosimilars. The Korean Ministry of Health and Welfare reported that the country produced over 80% of its biopharmaceuticals locally in recent years, leading to an impressive annual growth rate of around 10% in this sector.This growth is further supported by large pharmaceutical companies like Samsung Biologics and SK Biopharmaceuticals, which are investing heavily in advanced manufacturing technologies, including hydrophobic interaction chromatography techniques. The rising demand for monoclonal antibodies and other therapeutic proteins necessitates efficient purification technologies, propelling the demand for hydrophobic interaction chromatography applications in bioprocessing and downstream operations. ### **Growing Focus on Research and Development** The South Korea Hydrophobic Interaction Chromatography Market Industry is being driven by a strong emphasis on Research and Development (R&D) activities within the biopharmaceutical sector. The South Korean government has set ambitious R&D investment targets, allocating approximately 4.5% of its GDP towards R&D initiatives, significantly higher than the global average of 2.5%. This increase in funding supports academic institutions and private laboratories in developing better purification methods using hydrophobic interaction chromatography, facilitating breakthroughs in biological product development.Institutions like POSTECH, which focuses on biochemistry and biotechnology, are significantly advancing knowledge in this area. As a result, more sophisticated separation technologies are being developed, thereby necessitating the adoption of hydrophobic interaction chromatography for effective and high-yield biopharmaceutical production. ### **Rising Incidence of Chronic Diseases** The South Korea Hydrophobic Interaction Chromatography Market Industry is also being bolstered by the rising incidence of chronic diseases. According to the Ministry of Health and Welfare, the prevalence of chronic diseases in South Korea has surged over the past decade, with reports indicating that approximately 45% of the population is living with at least one chronic condition. This rise has led to an increasing demand for innovative treatment solutions, including biopharmaceuticals.Given that many chronic conditions require therapeutic proteins for effective treatment, the utilization of hydrophobic interaction chromatography will be crucial for the efficient purification of these products. Companies like LG Chem are focusing on developing new biologics to cater to this growing market, further driving the implementation of hydrophobic interaction chromatography in the production process. ## **South Korea Hydrophobic Interaction Chromatography Market Segment Insights****:** ### **Hydrophobic Interaction Chromatography Market Product and Service Insights** The South Korea Hydrophobic Interaction Chromatography Market is experiencing significant growth, particularly in the Product and Service segment, which encompasses various crucial components such as Resins, Columns, Services, and Others. With the increasing application of biomolecules in drug development and the rise in Research and Development activities within the pharmaceutical sector, Resins have become a vital element, offering efficient separation and purification processes that are essential for biopharmaceutical products.  Similarly, Columns play an important role in enhancing the performance and efficiency of hydrophobic interaction chromatography, ensuring greater throughput and resolution in analytical and preparative applications.As the demand for advanced bioprocessing solutions grows, the involvement of Services tied to hydrophobic interaction chromatography is also substantial, providing necessary technical support, training, and maintenance services that enhance the operational efficiencies for laboratories and industrial facilities.  Additionally, the Others category encompasses various ancillary products and innovations that contribute to the overall functioning and effectiveness of chromatography systems, reflecting the diversity of offerings within this segment.The prominence of the South Korea Hydrophobic Interaction Chromatography Market stems from a robust biopharmaceutical industry bolstered by government initiatives and investments in biotechnology, thereby solidifying its position in the global market. As organizations continue to focus on developing more effective therapeutic solutions, the significance of hydrophobic interaction chromatography technologies for drug purification and characterization is poised to increase markedly in South Korea, driven by this innovation-focused environment and the ongoing surge in scientific research. ## **South Korea Hydrophobic Interaction Chromatography Market Key Players and Competitive Insights****:** The South Korea Hydrophobic Interaction Chromatography Market is characterized by a dynamic competitive landscape, driven largely by the growing demand for protein purification and biopharmaceutical production. Hydrophobic interaction chromatography, known for its ability to separate biomolecules based on hydrophobicity, has garnered significant interest within the biotechnological and pharmaceutical sectors in South Korea. This region's robust investment in research and development, along with advances in bioprocessing technologies, is fostering an environment conducive to the proliferation of innovative chromatographic techniques.  As companies vie for market share, it is essential to analyze their strategic positioning, product offerings, and overall market strategies to gain insights into current trends and future opportunities within this specialized segment.Agilent Technologies has made a substantial impact in the South Korea Hydrophobic Interaction Chromatography Market, known for its cutting-edge technologies and strong product portfolio. The company boasts an extensive range of chromatography systems and columns tailored to meet the unique requirements of protein separations. Agilent's commitment to quality and innovation has positioned it as a trusted partner for various research institutions and biopharmaceutical firms in South Korea. With its robust support infrastructure, comprehensive customer service, and a solid reputation for reliability, Agilent Technologies has successfully established a strong presence in the market, enabling scientists and researchers to optimize their workflows and enhance productivity in protein research and purification applications. Cytiva, known for its dedication to advancing the field of bioprocessing, has also established a notable footprint in the South Korea Hydrophobic Interaction Chromatography Market. The company offers a wide range of key products, including its prepacked chromatography columns and media designed specifically for protein purification. Cytiva’s strengths lie in its innovation-driven approach, evidenced by its ongoing investments in research and development within the South Korean market. The company has engaged in strategic partnerships and collaborations that enhance its market positioning, reinforcing its commitment to supporting biopharmaceutical production processes. Additionally, Cytiva has expanded its offerings through strategic mergers and acquisitions, allowing it to combine advanced technologies and expand its product range, thus providing more comprehensive solutions to its customers in South Korea's biopharmaceutical industry. ### **Key Companies in the South Korea Hydrophobic Interaction Chromatography Market Include:** - Agilent Technologies - Cytiva - Repligen Corporation - Hitachi HighTechnologies - Merck KGaA - Waters Corporation - Sartorius AG - Pall Corporation - Emerson Electric - BioRad Laboratories - Boehringer Ingelheim - Thermo Fisher Scientific - MilliporeSigma - Tosoh Corporation - GE Healthcare ## **South Korea Hydrophobic Interaction Chromatography Market Industry Developments** Significant developments are currently shaping the South Korea Hydrophobic Interaction Chromatography Market, with major companies like Agilent Technologies, Cytiva, and Waters Corporation actively expanding their portfolio and technologies in this sector. The market has seen a notable demand surge due to increasing biopharmaceutical investments, specifically in protein purification and analysis. In recent months, Merck KGaA has announced plans to enhance its offerings in chromatographic solutions, reflecting the ongoing growth trajectory in the industry as presented in the South Korean government reports highlighting advancements in biomanufacturing. Moreover, the market is witnessing increased collaboration and innovation among leading entities.  In a notable move, Thermo Fisher Scientific announced an acquisition in July 2023 aimed at strengthening its capabilities in the chromatography sector. Additionally, growth in market valuation is evident, with companies like Repligen Corporation and Sartorius AG reporting substantial increases in their market share and revenue in the last two years, driven by the expanding scope of hydrophobic interaction chromatography applications in drug development and clinical research. Overall, the South Korean Hydrophobic Interaction Chromatography Market is experiencing significant growth spurred by advancements and strategic initiatives from key players. ## **South Korea Hydrophobic Interaction Chromatography Market Segmentation Insights** ### **Hydrophobic Interaction Chromatography Market Product and Service****Outlook** - Resins - Columns - Services - Others ## Market Drivers ### Growing Focus on Quality Control Quality control remains a critical aspect of biopharmaceutical production, significantly impacting the hydrophobic interaction-chromatography market. In South Korea, stringent regulatory requirements necessitate the implementation of effective purification methods to ensure product safety and efficacy. The hydrophobic interaction-chromatography market is likely to benefit from this focus on quality, as companies adopt advanced techniques to meet compliance standards. The increasing complexity of biopharmaceuticals, including the need for higher purity levels, drives the demand for sophisticated separation methods. As a result, the hydrophobic interaction-chromatography market is positioned to grow, as manufacturers prioritize quality assurance in their production processes. ### Emergence of Personalized Medicine The rise of personalized medicine is influencing the hydrophobic interaction-chromatography market in South Korea. As healthcare shifts towards tailored therapies, the demand for biopharmaceuticals that cater to individual patient needs is increasing. This trend necessitates the development of innovative purification techniques, including hydrophobic interaction chromatography, to isolate and purify specific biomolecules effectively. The market is likely to expand as biopharmaceutical companies invest in research to create personalized treatments, which often require advanced separation technologies. The ability to efficiently purify complex mixtures will be crucial in meeting the demands of personalized medicine, thereby driving growth in the hydrophobic interaction-chromatography market. ### Rising Investment in Biotechnology Investment in biotechnology is a key driver for the hydrophobic interaction-chromatography market in South Korea. The government and private sector are increasingly allocating funds to biotechnology research and development, with investments reaching approximately $1.5 billion in recent years. This financial support fosters innovation and the development of new bioprocessing techniques, including hydrophobic interaction chromatography. As research institutions and companies seek to enhance their capabilities in protein purification and separation, the demand for advanced chromatography solutions is expected to rise. This trend indicates a robust growth trajectory for the hydrophobic interaction-chromatography market, as stakeholders aim to leverage cutting-edge technologies to improve product yields and quality. ### Advancements in Analytical Techniques Advancements in analytical techniques are propelling the hydrophobic interaction-chromatography market in South Korea. The integration of cutting-edge technologies, such as high-performance liquid chromatography (HPLC) and mass spectrometry, enhances the efficiency and accuracy of purification processes. These innovations allow for better characterization of biomolecules, which is essential for biopharmaceutical development. As analytical capabilities improve, the demand for hydrophobic interaction chromatography is likely to increase, as it plays a vital role in the purification of complex biological products. The hydrophobic interaction-chromatography market is expected to benefit from these advancements, as companies seek to optimize their processes and improve product quality. ### Increasing Biopharmaceutical Production The hydrophobic interaction-chromatography market is experiencing growth due to the increasing production of biopharmaceuticals in South Korea. The country has established itself as a hub for biopharmaceutical manufacturing, with a projected market value of approximately $3 billion by 2026. This surge in production necessitates advanced purification techniques, such as hydrophobic interaction chromatography, to ensure the quality and efficacy of biopharmaceutical products. As companies strive to meet regulatory standards and consumer demands, the reliance on effective separation methods is likely to drive the hydrophobic interaction-chromatography market forward. Furthermore, the emphasis on developing innovative therapies, including monoclonal antibodies and recombinant proteins, further fuels the need for efficient purification processes, thereby enhancing the market's growth prospects. ## Future Outlook The [Hydrophobic Interaction Chromatography Market](https://www.marketresearchfuture.com/reports/hydrophobic-interaction-chromatography-market-6366) is projected to grow at 11.51% CAGR from 2025 to 2035, driven by increasing demand for biopharmaceuticals and advancements in purification technologies. **New opportunities:** - Development of high-capacity resin technologies for enhanced separation efficiency. Expansion of contract manufacturing services for biopharmaceutical companies. Integration of automation in chromatography systems to reduce operational costs. By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in bioprocessing solutions. ## Segment Insights ### By Product and Service: Resins (Largest) vs. Buffers (Fastest-Growing) In the South Korea hydrophobic interaction-chromatography market, the product and service segment displays a diverse distribution of market share among key offerings. Resins currently hold the largest share, favored for their efficiency and reliability in various applications. Meanwhile, buffers are emerging as a significant player, experiencing swift growth due to their essential role in the purification processes of biopharmaceuticals. The growth trends within this segment are shaped by increasing demands in biotechnology and pharmaceutical sectors, which drive innovation and the adoption of advanced products. The expansion of research in life sciences and an upsurge in biomanufacturing practices further amplify the importance of these products. As a result, the market for buffers is expected to witness rapid development, aligning with the overall upward trajectory of the sector. Resins (Dominant) vs. Other Products and Services (Emerging) Resins are positioned as the dominant force in the South Korea hydrophobic interaction-chromatography market due to their widespread application in various chromatography techniques. Their robustness and ability to facilitate high-resolution separation processes make them integral to laboratories and production units. In contrast, other products and services, including specialized buffers and equipment, represent an emerging category that is gaining importance as the industry evolves. These offerings are increasingly tailored to meet the specific needs of modern biopharmaceutical processes, catering to a shift toward more personalized and targeted therapeutics. As the landscape shifts, these emerging products and services are likely to carve out increased market share. ### By Sample Type: Monoclonal Antibodies (Largest) vs. Vaccines (Fastest-Growing) In the South Korea hydrophobic interaction-chromatography market, the share of Monoclonal Antibodies is the largest among the various sample types, reflecting the robust demand for therapeutic antibodies in drug development and production. Vaccines, while having a smaller market share, are experiencing significant growth and increasing attention from manufacturers due to the rise in vaccine development and production capacities. The growth trends are driven by the ongoing advancements in biopharmaceutical research, particularly in the fields of oncology and immunotherapy. The rapid increase in research funding for vaccine-related studies, along with the establishment of new biomanufacturing facilities, enhances the capacity for both Monoclonal Antibodies and Vaccines. As public health awareness grows, these sample types are expected to see escalated investments and innovations, making them key players in this market. Monoclonal Antibodies (Dominant) vs. Vaccines (Emerging) Monoclonal Antibodies remain the dominant force in the South Korea hydrophobic interaction-chromatography market, being widely utilized in therapeutic applications due to their specificity and efficacy. The technology involved in producing these antibodies has advanced, leading to greater yields and enhanced purification processes. On the other hand, Vaccines are emerging as a critical segment, especially amidst recent global health challenges that have amplified the focus on vaccine development. The flexibility in manufacturing methods and the evolving platforms for vaccine production enable companies to respond swiftly to emerging health needs, driving innovation. The competition between these two segments reflects the changing priorities in biopharmaceutical developments. ### By End-User: Pharmaceutical & Biopharmaceutical Companies (Largest) vs. Contract Research Organizations & Contract Manufacturing Organizations (Fastest-Growing) In the South Korea hydrophobic interaction-chromatography market, Pharmaceutical & Biopharmaceutical Companies represent the largest segment, significantly influencing the overall market dynamics due to their extensive R&D activities and demand for biologics. In contrast, Contract Research Organizations & Contract Manufacturing Organizations are witnessing rapid growth, driven by the increasing outsourcing trends among pharmaceutical companies seeking to enhance operational efficiency and reduce costs. Growth in this market segment is primarily fueled by the rising need for advanced purification techniques that support biopharmaceutical production. Additionally, the expansion of research activities in various academic institutes and the adoption of cutting-edge technologies by Contract Research Organizations foster an environment conducive to innovation, thereby driving market growth for hydrophobic interaction chromatography solutions. Pharmaceutical & Biopharmaceutical Companies (Dominant) vs. Contract Research Organizations & Contract Manufacturing Organizations (Emerging) The Pharmaceutical & Biopharmaceutical Companies segment is characterized by its dominant position in the South Korea hydrophobic interaction-chromatography market, supported by substantial investments in biopharmaceutical research and development. This segment not only drives demand for advanced purification methods but also showcases a strong preference for bespoke solutions tailored to specific production needs. On the other hand, Contract Research Organizations & Contract Manufacturing Organizations are emerging as critical players, leveraging their agility and expertise to offer comprehensive services that meet the varied demands of pharmaceutical clients. This shift towards outsourcing is revolutionizing the market landscape, positioning these organizations as essential partners in biopharmaceutical development and manufacturing. ## Competitive Benchmarking The hydrophobic interaction-chromatography market in South Korea is characterized by a dynamic competitive landscape, driven by increasing demand for biopharmaceuticals and advancements in protein purification technologies. Key players such as GE Healthcare (US), Thermo Fisher Scientific (US), and Merck KGaA (DE) are strategically positioned to leverage innovation and regional expansion. GE Healthcare (US) focuses on enhancing its product portfolio through continuous innovation, while Thermo Fisher Scientific (US) emphasizes strategic partnerships to broaden its market reach. Merck KGaA (DE) appears to be concentrating on sustainability initiatives, which may resonate well with the growing emphasis on environmentally friendly practices in the industry. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological advancement and customer-centric solutions. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure is moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to thrive, while larger corporations consolidate their market positions through strategic acquisitions and partnerships. The collective influence of these key players shapes the market dynamics, fostering an environment where innovation and responsiveness to customer needs are paramount. In October 2025, GE Healthcare (US) announced the launch of a new line of hydrophobic interaction chromatography resins designed to improve protein purification efficiency. This strategic move is likely to enhance their competitive edge by addressing the specific needs of biopharmaceutical manufacturers, thereby solidifying their market position. The introduction of these advanced resins may also reflect a broader trend towards customization in chromatography solutions, catering to the unique requirements of diverse applications. In September 2025, Thermo Fisher Scientific (US) expanded its collaboration with a leading South Korean biopharmaceutical company to develop integrated solutions for protein purification. This partnership is indicative of a strategic focus on co-innovation, which may enhance Thermo Fisher's capabilities in delivering tailored solutions to local clients. Such collaborations not only strengthen market presence but also foster innovation through shared expertise and resources. In August 2025, Merck KGaA (DE) unveiled a sustainability initiative aimed at reducing the environmental impact of its chromatography products. This initiative includes the development of eco-friendly resins and a commitment to sustainable manufacturing practices. The strategic importance of this move lies in its alignment with global sustainability trends, potentially attracting environmentally conscious customers and enhancing brand loyalty. As of November 2025, current competitive trends in the hydrophobic interaction-chromatography market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in operational processes. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise for enhanced innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and sustainable practices. This shift may redefine market dynamics, compelling companies to innovate continuously to maintain their competitive edge. ## Recent News & Developments Significant developments are currently shaping the South Korea Hydrophobic Interaction Chromatography Market, with major companies like Agilent Technologies, Cytiva, and Waters Corporation actively expanding their portfolio and technologies in this sector. The market has seen a notable demand surge due to increasing biopharmaceutical investments, specifically in protein purification and analysis. In recent months, Merck KGaA has announced plans to enhance its offerings in chromatographic solutions, reflecting the ongoing growth trajectory in the industry as presented in the South Korean government reports highlighting advancements in biomanufacturing. Moreover, the market is witnessing increased collaboration and innovation among leading entities.  In a notable move, Thermo Fisher Scientific announced an acquisition in July 2023 aimed at strengthening its capabilities in the chromatography sector. Additionally, growth in market valuation is evident, with companies like Repligen Corporation and Sartorius AG reporting substantial increases in their market share and revenue in the last two years, driven by the expanding scope of hydrophobic interaction chromatography applications in drug development and clinical research. Overall, the South Korean Hydrophobic Interaction Chromatography Market is experiencing significant growth spurred by advancements and strategic initiatives from key players. ## Report Scope | MARKET SIZE 2024 | 16.72(USD Million) | | --- | --- | | MARKET SIZE 2025 | 18.64(USD Million) | | MARKET SIZE 2035 | 55.43(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.51% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Bio-Rad Laboratories (US), Agilent Technologies (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) | | Segments Covered | Product and Service, Sample Type, End-User | | Key Market Opportunities | Growing demand for biopharmaceuticals drives innovation in the hydrophobic interaction-chromatography market. | | Key Market Dynamics | Rising demand for biopharmaceuticals drives innovation and competition in the hydrophobic interaction-chromatography market. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What is the projected market valuation for the hydrophobic interaction-chromatography market in South Korea by 2035?** A: The projected market valuation for the hydrophobic interaction-chromatography market in South Korea by 2035 is $55.43 Million. **Q: What was the market valuation for the hydrophobic interaction-chromatography market in South Korea in 2024?** A: The market valuation for the hydrophobic interaction-chromatography market in South Korea in 2024 was $16.72 Million. **Q: What is the expected CAGR for the hydrophobic interaction-chromatography market in South Korea during the forecast period 2025 - 2035?** A: The expected CAGR for the hydrophobic interaction-chromatography market in South Korea during the forecast period 2025 - 2035 is 11.51%. **Q: Which companies are considered key players in the South Korean hydrophobic interaction-chromatography market?** A: Key players in the South Korean hydrophobic interaction-chromatography market include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Agilent Technologies, Waters Corporation, Pall Corporation, and Repligen Corporation. **Q: What are the main product segments in the South Korean hydrophobic interaction-chromatography market?** A: The main product segments in the South Korean hydrophobic interaction-chromatography market include Resins, Columns, Buffers, and Other Products and Services. **Q: How did the revenue from Resins in the hydrophobic interaction-chromatography market perform in 2024?** A: In 2024, the revenue from Resins in the hydrophobic interaction-chromatography market was $5.01 Million. **Q: What is the revenue forecast for Monoclonal Antibodies in the hydrophobic interaction-chromatography market by 2035?** A: The revenue forecast for Monoclonal Antibodies in the hydrophobic interaction-chromatography market by 2035 is $22.12 Million. **Q: Which end-user segment contributed the most to the hydrophobic interaction-chromatography market in 2024?** A: In 2024, the Pharmaceutical & Biopharmaceutical Companies segment contributed the most to the hydrophobic interaction-chromatography market, generating $6.68 Million. **Q: What is the expected revenue from Buffers in the hydrophobic interaction-chromatography market by 2035?** A: The expected revenue from Buffers in the hydrophobic interaction-chromatography market by 2035 is $11.5 Million. **Q: How does the revenue from Contract Research Organizations compare to other end-user segments in 2024?** A: In 2024, the revenue from Contract Research Organizations was $4.16 Million, which is lower than the revenue from Pharmaceutical & Biopharmaceutical Companies but higher than Research & Academic Institutes. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-hydrophobic-interaction-chromatography-market-56494*